CNSX:VIDA Vidaroo (VIDA) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free VIDA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume9,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vidaroo alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About VidarooPhivida Holdings Inc., a functional food and beverage company, engages in purchasing, packaging, and selling holistic hemp infused remedies in the United States. The company offers hemp oil infused beverages under the OKI brand; and tinctures and capsules under the Vida + brand, as well as sells cannabis accessories. It also operates e-commerce platforms under the Greencamp, bloomgrove, and Wikala brand names. The company was formerly known as Phytofarms Holdings Inc. and changed its name to Phivida Holdings Inc. in January 2017. Phivida Holdings Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> VIDA Stock News HeadlinesJanuary 23, 2024 | ca.finance.yahoo.comVidaroo Corporation (VIDA) Stock Historical Prices & Data - Yahoo FinanceMarch 31, 2023 | finance.yahoo.comVidaroo Corp (VIDA) Stock Historical Prices & Data - Yahoo FinanceApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.September 2, 2022 | reuters.comVIDA.PK - | Stock Price & Latest News | ReutersSee More Headlines Receive VIDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vidaroo and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:VIDA CUSIPN/A CIKN/A Webphivida.com Phone844 744 6646FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. David MoonInterim CEO & DirectorMr. Carmelo Marrelli C.A. (Age 49)C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer Comp: $61.46kMr. George Kovalyov (Age 35)VP of Fin. Comp: $175kMr. Graham MageeVP of Operations & SalesMr. John David Belfontaine (Age 41)VP of Corp. Devel. Key CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors VIDA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Vidaroo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vidaroo investors own include BooksAMillion (BAMM), Cresco Labs (CRLBF), Curaleaf (CURLF), CV Sciences (CVSI), EnWave (ENW), Flower One (FLOOF), iAnthus Capital (ITHUF), KushCo (KSHB) and MPX International (MPXOF). How do I buy shares of Vidaroo? Shares of VIDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:VIDA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vidaroo Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
